Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1162)	6/27/2005 12:08:40 PM
From: Jibacoa	Read Replies (2) of 3722

NTEC (The company that uses its glycoadvance,glycopeglation and glyconugation tech. for glycoprotein therapies.<g> ) Seems to have found support at the 2.05 level and has some upticks on late trading on regular time Friday. The stock has been up more than 5% today (intraday H at 10.05AM was 2.57 ) and has had a couple of small intraday upgaps.<g> There were some insiders buying in February at $4 and in May at $2.80 and $2.75 It seems the RR is low at present levels since it has been trimming its loss and revenue has shown improvement in last 2 Qs. It reportedly has around $1.96 in cash/shr with Debt/Equt ratio around 0.22 On Thursday it announced that it has submitted an IND for its NE- 180, which is its long-acting, GlycoPEGylated erythropoietin for the treatment of anemia after chemotherapy and it expects to start a PI this year. Of course some people may like to wait until NTEC can close above its Apr.28 H of 3.17 <g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next